ADB-P7AICA: Difference between revisions

Latest revision as of 11:34, 15 February 2025

ADB-P7AICA[edit]

ADB-P7AICA is a synthetic cannabinoid that has been identified in various designer drug products. It is part of a class of compounds that are often used as substitutes for cannabis due to their psychoactive effects. These compounds are typically sprayed onto plant material and smoked, or they are sold as liquids to be vaporized in e-cigarettes.

Chemical Structure[edit]

ADB-P7AICA is chemically related to other synthetic cannabinoids, which are designed to mimic the effects of tetrahydrocannabinol (THC), the active component of cannabis. The structure of ADB-P7AICA includes a core indazole structure, which is common among many synthetic cannabinoids. The specific chemical structure of ADB-P7AICA is shown in the image to the right.

Pharmacology[edit]

Synthetic cannabinoids like ADB-P7AICA act on the cannabinoid receptors in the brain, primarily the CB1 receptor, which is responsible for the psychoactive effects of THC. These compounds can have a much higher potency than THC, leading to more intense effects and a higher risk of adverse reactions.

Legal Status[edit]

The legal status of ADB-P7AICA varies by country. Many jurisdictions have moved to ban synthetic cannabinoids due to their potential for abuse and the health risks they pose. In some regions, ADB-P7AICA may be classified as a controlled substance, making its sale, possession, and use illegal.

Health Risks[edit]

The use of synthetic cannabinoids like ADB-P7AICA has been associated with a range of adverse health effects. These can include tachycardia, hypertension, nausea, vomiting, hallucinations, and seizures. In some cases, use of these substances has been linked to severe outcomes, including acute kidney injury and death.

Related Pages[edit]

@@ Line 1: / Line 1: @@
-ADB-P7AICA
+== ADB-P7AICA ==
 [[File:ADB-P7AICA_structure.png|thumb|right|Chemical structure of ADB-P7AICA]]
-'''ADB-P7AICA''' is a synthetic cannabinoid that has been identified in various designer drug products. It is a potent agonist of the [[cannabinoid receptor]]s and is structurally related to other compounds in the indazole-3-carboxamide family.
+'''ADB-P7AICA''' is a synthetic cannabinoid that has been identified in various designer drug products. It is part of a class of compounds that are often used as substitutes for [[cannabis]] due to their psychoactive effects. These compounds are typically sprayed onto plant material and smoked, or they are sold as liquids to be vaporized in e-cigarettes.
-==Chemical Structure==
+=== Chemical Structure ===
-ADB-P7AICA is characterized by its indazole core, which is a common feature among synthetic cannabinoids. The chemical structure includes an amide linkage and a pentyl side chain, which contribute to its binding affinity and activity at the cannabinoid receptors.
-==Pharmacology==
+ADB-P7AICA is chemically related to other synthetic cannabinoids, which are designed to mimic the effects of [[tetrahydrocannabinol]] (THC), the active component of cannabis. The structure of ADB-P7AICA includes a core indazole structure, which is common among many synthetic cannabinoids. The specific chemical structure of ADB-P7AICA is shown in the image to the right.
-As a synthetic cannabinoid, ADB-P7AICA acts primarily on the [[CB1 receptor|CB1]] and [[CB2 receptor|CB2]] receptors in the [[endocannabinoid system]]. These receptors are part of the [[G protein-coupled receptor]] family and are involved in various physiological processes, including pain sensation, mood regulation, and appetite control.
-==Effects==
+=== Pharmacology ===
-The effects of ADB-P7AICA are similar to those of other synthetic cannabinoids, which can include euphoria, altered perception, and relaxation. However, due to its potency, it may also cause adverse effects such as anxiety, paranoia, and cardiovascular issues.
-==Legal Status==
+Synthetic cannabinoids like ADB-P7AICA act on the [[cannabinoid receptor]]s in the brain, primarily the CB1 receptor, which is responsible for the psychoactive effects of THC. These compounds can have a much higher potency than THC, leading to more intense effects and a higher risk of adverse reactions.
-The legal status of ADB-P7AICA varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of medical use. Regulatory agencies continue to monitor and update the legal status of synthetic cannabinoids as new compounds are identified.
-==Synthesis==
+=== Legal Status ===
-The synthesis of ADB-P7AICA involves the reaction of an indazole derivative with a carboxylic acid or its derivative to form the amide bond. The specific synthetic route can vary, but it typically involves standard organic chemistry techniques such as amide coupling reactions.
-==Health Risks==
+The legal status of ADB-P7AICA varies by country. Many jurisdictions have moved to ban synthetic cannabinoids due to their potential for abuse and the health risks they pose. In some regions, ADB-P7AICA may be classified as a controlled substance, making its sale, possession, and use illegal.
-The use of ADB-P7AICA poses significant health risks, particularly due to its high potency and the potential for overdose. Users may experience severe side effects, and there is a risk of developing [[substance use disorder]] with repeated use.
-==Related pages==
+=== Health Risks ===
+The use of synthetic cannabinoids like ADB-P7AICA has been associated with a range of adverse health effects. These can include [[tachycardia]], [[hypertension]], [[nausea]], [[vomiting]], [[hallucinations]], and [[seizures]]. In some cases, use of these substances has been linked to severe outcomes, including [[acute kidney injury]] and [[death]].
+== Related Pages ==
 * [[Synthetic cannabinoids]]
 * [[Cannabinoid receptor]]
-* [[Endocannabinoid system]]
+* [[Tetrahydrocannabinol]]
 * [[Designer drugs]]
 [[Category:Synthetic cannabinoids]]
-[[Category:Designer drugs]]